Thrombolex

Thrombolex

Medical Devices, 75 Britain Dr, Doylestown, Pennsylvania, 18901, United States, 11-50 Employees

thrombolex.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 12***********

Who is THROMBOLEX

Thrombolex is engaged in the design, development, and distribution of innovative endovascular catheters used in interventional procedures, particularly in pharmaco-mechanical catheter-dir...

Read More

map
  • 75 Britain Dr, Doylestown, Pennsylvania, 18901, United States Headquarters: 75 Britain Dr, Doylestown, Pennsylvania, 18901, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from THROMBOLEX

Thrombolex Org Chart and Mapping

Employees

Brian Firth

Chief Scientific Officer and Board Member

John Cerminaro

Chief Financial Officer

Amy Katsikis

QA & Operations Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Thrombolex

Answer: Thrombolex's headquarters are located at 75 Britain Dr, Doylestown, Pennsylvania, 18901, United States

Answer: Thrombolex's phone number is 12***********

Answer: Thrombolex's official website is https://thrombolex.com

Answer: Thrombolex's revenue is $5 Million to $10 Million

Answer: Thrombolex's SIC: 3841

Answer: Thrombolex's NAICS: 339112

Answer: Thrombolex has 11-50 employees

Answer: Thrombolex is in Medical Devices

Answer: Thrombolex contact info: Phone number: 12*********** Website: https://thrombolex.com

Answer: Thrombolex is engaged in the design, development, and distribution of innovative endovascular catheters used in interventional procedures, particularly in pharmaco-mechanical catheter-directed thrombolysis (PM-CDT) in patients who suffer from arterial and venous thromboembolic (A&VTE) conditions. The Company is currently marketing seven (7) different FDA-cleared devices that are all based on the BASHIRTM Endovascular Catheter platform technology.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access